1. Pink Sheet
  2. >>Geography

EU Regulatory System Attacked Over Quality Of Approvals

Drug Bulletin Says Some Products Should Not Have Been Authorized

 
• By Ian Schofield

If anyone can throw cold water on the claimed benefits of some of Europe's most recently approved medicines, it’s the international drug bulletin, Prescrire. In an assessment of 108 of the pharma industry’s latest offerings, it gives a cautious welcome to some but says that more than half bring nothing new and others could even be dangerous to patients.

Pills_In_Hands
Pharma's new product offerings are under close scrutiny • Source: Shutterstock

The independent drug bulletin, Prescrire, has attacked the EU’s drug regulatory system, claiming that it “continues to take the side of companies” and fails to sufficiently protect patients from potentially dangerous products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography